HUMAN HEALTH AND GRAIN LEGUMES Anna Arnoldi Dipartimento di Endocrinologia, Fisiopatologia e Biologia Applicata, Università degli Studi di Milano, via Balzaretti 9, Milano (anna.arnoldi@unimi.it) About ten years ago the U.S. Food and Drug Administration approved the health claim on soy foods for the prevention of high cholesterol, confirming the outcomes of numerous clinical studies conducted all over the world. At present, a similar health claim is pending in the European Union. Detailed studies have shown that the proteins have a predominant role in the cholesterol-lowering activity of soy (1). Since most legume proteins have considerable sequence homology, several groups, including ours, have undertaken studies on these vegetables. The most investigated are bean (a term indicating several species of the genera Phaseolus and Vigna), pea, faba bean, chickpea and lupin. Numerous experimental studies (2) in different animal models and a few clinical studies are available, which have indicated interesting pharmacological activities, against hypercholesterolemia, hypertension and hyperglycemia. Besides proteins, other nutraceuticals in legumes are resistant starch, soluble fibers, alpha-galactosides, unsaturated fatty acids (including alpha-linolenic acid) and antioxidant polyphenols. In addition, legumes also contain relevant amounts of macro and micro-elements and vitamins. Our attention was primarily focused on lupin whose composition is very similar to soy (high protein content, reduced presence of starch, relatively high concentrations of alpha-linolenic acid). Experimental studies in a rat model of hypercholesterolemia (3) and in a rabbit model of the atherosclerotic plaque, and a double-blind clinical study on moderately hypercholesterolemic patients have shown interesting activities. Another clinical study performed in Australia has shown, instead, a potential hypotensive activity (4). Bibliografia 1. Duranti M, et al. J Nutr 2004; 134:1334-1339 2. Sirtori CR, et al. Atherosclerosis 2009; 203:8-17 3. Sirtori CR, et al. J Nutr 2004; 134:18-23 4. Lee YM, et al. Eur J Nutr 2007; 46:21-27

Grain legumes and human health / A. Arnoldi. ((Intervento presentato al convegno 5. International Food Legume Research Conference (IFLRC) & 7. European Conference on Grain Legumes (AEP) tenutosi a Antalya nel 2010.

Grain legumes and human health

A. Arnoldi
Primo
2010

Abstract

HUMAN HEALTH AND GRAIN LEGUMES Anna Arnoldi Dipartimento di Endocrinologia, Fisiopatologia e Biologia Applicata, Università degli Studi di Milano, via Balzaretti 9, Milano (anna.arnoldi@unimi.it) About ten years ago the U.S. Food and Drug Administration approved the health claim on soy foods for the prevention of high cholesterol, confirming the outcomes of numerous clinical studies conducted all over the world. At present, a similar health claim is pending in the European Union. Detailed studies have shown that the proteins have a predominant role in the cholesterol-lowering activity of soy (1). Since most legume proteins have considerable sequence homology, several groups, including ours, have undertaken studies on these vegetables. The most investigated are bean (a term indicating several species of the genera Phaseolus and Vigna), pea, faba bean, chickpea and lupin. Numerous experimental studies (2) in different animal models and a few clinical studies are available, which have indicated interesting pharmacological activities, against hypercholesterolemia, hypertension and hyperglycemia. Besides proteins, other nutraceuticals in legumes are resistant starch, soluble fibers, alpha-galactosides, unsaturated fatty acids (including alpha-linolenic acid) and antioxidant polyphenols. In addition, legumes also contain relevant amounts of macro and micro-elements and vitamins. Our attention was primarily focused on lupin whose composition is very similar to soy (high protein content, reduced presence of starch, relatively high concentrations of alpha-linolenic acid). Experimental studies in a rat model of hypercholesterolemia (3) and in a rabbit model of the atherosclerotic plaque, and a double-blind clinical study on moderately hypercholesterolemic patients have shown interesting activities. Another clinical study performed in Australia has shown, instead, a potential hypotensive activity (4). Bibliografia 1. Duranti M, et al. J Nutr 2004; 134:1334-1339 2. Sirtori CR, et al. Atherosclerosis 2009; 203:8-17 3. Sirtori CR, et al. J Nutr 2004; 134:18-23 4. Lee YM, et al. Eur J Nutr 2007; 46:21-27
30-apr-2010
Settore CHIM/10 - Chimica degli Alimenti
Grain legumes and human health / A. Arnoldi. ((Intervento presentato al convegno 5. International Food Legume Research Conference (IFLRC) & 7. European Conference on Grain Legumes (AEP) tenutosi a Antalya nel 2010.
Conference Object
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/160144
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact